Therapeutic Inertia in People With Type 2 Diabetes in Primary Care: A Challenge That Just Won’t Go Away | Zendy

Nemin Adam Zhu | Zendy; Stewart B. Harris | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapeutic Inertia in People With Type 2 Diabetes in Primary Care: A Challenge That Just Won’t Go Away

Author(s) -

Nemin Adam Zhu,

Stewart B. Harris

Publication year - 2020

Publication title -

diabetes spectrum

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.716

H-Index - 31

eISSN - 1944-7353

pISSN - 1040-9165

DOI - 10.2337/ds19-0016

Subject(s) - medicine , glycemic , primary care , type 2 diabetes , diabetes mellitus , inertia , intensive care medicine , family medicine , physics , classical mechanics , endocrinology

Therapeutic inertia is a prevalent problem in people with type 2 diabetes in primary care and affects clinical outcomes. It arises from a complex interplay of patient-, clinician-, and health system–related factors. Ultimately, clinical practice guidelines have not made an impact on improving glycemic targets over the past decade. A more proactive approach, including focusing on optimal combination agents for early glycemic durability, may reduce therapeutic inertia and improve clinical outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research